enVVeno Medical Corporation cash flow to debt ratio of -2.22K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

enVVeno Medical Corporation's free cash flow has increased -7.72% from $-16.88M last year to $-15.57M, signaling increasing performance

enVVeno Medical Corporation's debt to equity ratio is 0.03, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

enVVeno Medical Corporation's debt has increased relative to shareholder equity from 0.03 last year to 0.03 today, signaling weakened financials

enVVeno Medical Corporation has negative EBITDA, making leverage ratio unreliable

enVVeno Medical Corporation earns at least as much interest as it pays. Interest obligations are fully covered.

enVVeno Medical Corporation has insufficient data to evaluate this check.

enVVeno Medical Corporation's short-term assets of $28.83M exceed its short-term liabilities of $2.12M

enVVeno Medical Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

enVVeno Medical Corporation's return on equity of -66.39%, is lower than 15.00%, indicating bad performance

enVVeno Medical Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

enVVeno Medical Corporation had positive net income in only 0.00 out of 5 years, indicating unstable earnings

enVVeno Medical Corporation has negative free cash flow, indicating the company is burning cash rather than generating it

enVVeno Medical Corporation has negative free cash flow, indicating cash burn

enVVeno Medical Corporation's yearly earnings has increased -10.76% since last year from $-21.82M to $-19.47M, signaling increasing performance

enVVeno Medical Corporation's yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -82.16% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

enVVeno Medical Corporation has insufficient revenue history to calculate 3-year revenue CAGR.

enVVeno Medical Corporation had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

enVVeno Medical Corporation had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

enVVeno Medical Corporation has insufficient data to evaluate this check.

enVVeno Medical Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

enVVeno Medical Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

enVVeno Medical Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable

enVVeno Medical Corporation has insufficient data to evaluate this check.

enVVeno Medical Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

enVVeno Medical Corporation has a price-to-book ratio of 0.01x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

enVVeno Medical Corporation has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue